Literature DB >> 28060043

Chikungunya Infection in Hospitalized Febrile Infants Younger Than 3 Months of Age.

Narcisse Elenga1, Marion Folin, Yves-Marie Vandamme, Emma Cuadro-Alvarez, Laurence Long, Falucar Njuieyon, Elise Martin, Rémi Kom-Tchameni, Antoine Defo, Sitraka Herinantenaina Razafindrakoto, Yajaira Mrsic, Pierre Couppie, Mathieu Nacher, Julie Dufour.   

Abstract

BACKGROUND: Fever in infants younger than 3 months is generally a cause for concern because of the risk for a serious bacterial infection. The aim of this study was to describe clinical and biologic features of Chikungunya infection in infants <3 months of age hospitalized in Cayenne Hospital during the 2014-2015 outbreak.
METHODS: We performed a preliminary retrospective study followed by a prospective study from March 2014 to February 2015. All infants younger than 3 months presenting with fever and hospitalized in Cayenne Hospital were included. The main diagnostic criteria were fever and positive Chikungunya polymerase chain reaction.
RESULTS: One hundred and twenty infants were hospitalized with fever. The mean age was 46 days (standard deviation ± 22 days). The mean hospitalization duration was 7.4 days (standard deviation ± 6.1 days). Chikungunya infection was diagnosed in 26 children. The most important clinical findings were high [80.8% (77.5-84)] and prolonged fever [76.9% (73.4-80.4)], irritability [96.2% (94.5-97.7)] and skin rash [69.2% (65.4-73)]. Half of the infants presented edema of the extremities (hands and feet principally). However, in 15% of infants, Chikungunya infection was associated with a serious bacterial infection. Infants who presented with irritability, high fever and elevated PCT were at high risk for Chikungunya: OR 39 (9.2-243; P < .001), with a specificity of 96.7% and a negative predictive value of 89.4%. The area of the receiver operating characteristic curve was 0.96.
CONCLUSIONS: Our results confirm that Chikunguyna infection is a cause of high fever in infants younger than 3 months. Our data should be confirmed by larger studies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28060043     DOI: 10.1097/INF.0000000000001541

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

Review 1.  Chikungunya in Infants and Children: Is Pathogenesis Increasing?

Authors:  Kelli L Barr; Vedana Vaidhyanathan
Journal:  Viruses       Date:  2019-03-23       Impact factor: 5.048

2.  Risk factors for hospitalization of patients with chikungunya virus infection at sentinel hospitals in Puerto Rico.

Authors:  Christopher H Hsu; Fabiola Cruz-Lopez; Danulka Vargas Torres; Janice Perez-Padilla; Olga D Lorenzi; Aidsa Rivera; J Erin Staples; Esteban Lugo; Jorge Munoz-Jordan; Marc Fischer; Carlos Garcia Gubern; Brenda Rivera Garcia; Luisa Alvarado; Tyler M Sharp
Journal:  PLoS Negl Trop Dis       Date:  2019-01-14

3.  Pre and postnatal exposure to Chikungunya virus does not affect child neurodevelopmental outcomes at two years of age.

Authors:  Randall Waechter; Erinique Ingraham; Roberta Evans; Nikita Cudjoe; Amy Krystosik; Rashida Isaac; Ashlee Watts; Trevor Noël; Barbara Landon; Michelle Fernandes; Veronica Mapp-Alexander; Priyanka Suresh; George Mitchell; Calum Macpherson; Patrick Gérardin; A Desiree LaBeaud
Journal:  PLoS Negl Trop Dis       Date:  2020-10-05

Review 4.  Contribution of Research in the West Indies and Northeast Amazonia to Knowledge of the 2014-2015 Chikungunya Epidemic in the Americas.

Authors:  Timothee Bonifay; Lidvine Godaert; Yanouk Epelboin; Dominique Rousset; Maylis Douine; Hélène Hilderal; Cyril Clavel; Sylvie Abel; Fatiha Najioullah; Laurence Fagour; Margarete do Socorro Mendonça Gomes; Marcus Lacerda; Raymond Cézaire; Narcisse Elenga; Moustapha Dramé; Bruno Hoen; André Cabié; Félix Djossou; Loïc Epelboin
Journal:  Curr Trop Med Rep       Date:  2021-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.